Sfoglia per AUTORE
DE NICOLò A
Collezione ASL Città di Torino

  

Items : 105

UHPLC-MS/MS method for the simultaneous quantification of five calcium channel antagonists' drugs in human plasma. in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie / Biomed Pharmacother. 2025 Mar;184:117873. doi: 10.1016/j.biopha.2025.117873. Epub 2025 Feb 5.
2025
ASL Città di Torino

Rabbia F; Cantù M; De Rosa FG; Fasano C; Ponsa L; Pappaccogli M; Menegatti G; Antonucci M; Manca A; Cusato J; De Nicolò A; Billi M; Palermiti A; Veglio F; D'Avolio A;

Clinical Pharmacology of Bulevirtide: Focus on Known and Potential Drug-Drug Interactions. in Pharmaceutics / Pharmaceutics. 2025 Feb 14;17(2):250. doi: 10.3390/pharmaceutics17020250.
2025
ASL Città di Torino

Billi M; Soloperto S; Bonora S; D'Avolio A; De Nicolò A;

Pharmacogenetics of tenofovir drug transporters in the context of HBV: Is there an impact? in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie / Biomed Pharmacother. 2024 Jun;175:116678. doi: 10.1016/j.biopha.2024.116678. Epub 2024 May 6.
2024
ASL Città di Torino
AOU San Luigi di Orbassano

Boglione L; D'Avolio A; De Nicolò A; Lupia T; Stroffolini G; Antonucci M; Chiara F; Mula J; Palermiti A; Manca A; Cusato J;

Low azithromycin maximal concentrations in patients concomitantly taking rifampicin: time to move away from rifampicin in the treatment of non-tuberculous mycobacteria? in Antimicrobial agents and chemotherapy / Antimicrob Agents Chemother. 2024 Jul 9;68(7):e0023424. doi: 10.1128/aac.00234-24. Epub 2024 May 24.
2024
ASL Città di Torino

D'Avolio A; Marinaro L; Alladio F; Ponzetta L; Cat Genova E; Quaranta M; Stroffolini G; Venuti F; de Nicolò A; Gaviraghi A; Calcagno A;

Pharmacokinetics of tecovirimat in subjects with Mpox. in International journal of antimicrobial agents / Int J Antimicrob Agents. 2024 Feb;63(2):107068. doi: 10.1016/j.ijantimicag.2023.107068. Epub 2023 De
2024
ASL Città di Torino

Tempestilli M; Mondi A; D'Avolio A; Forini O; Pinnetti C; Mazzotta V; Gagliardini R; Beccacece A; De Nicolò A; Faccendini P; Cimini E; Maggi F; Girardi E; Nicastri E; Boffito M; Vaia F; Antinori A;

Development and Validation of a UHPLC-MS/MS Method for the Simultaneous Quantification of Candesartan and Bisoprolol Together with Other 16 Antihypertensive Drugs in Plasma Samples. in Journal of medicinal chemistry / J Med Chem. 2024 Dec 26;67(24):22124-22133. doi: 10.1021/acs.jmedchem.4c02045. Epub 2024 Dec 4.
2024
ASL Città di Torino

Veglio F; Rabbia F; De Rosa FG; Fasano C; Ponsa L; Pappaccogli M; Carta A; Cusato J; Billi M; Mula J; Antonucci M; Manca A; De Nicolò A; Palermiti A; D'Avolio A;

2023
ASL Città di Torino

Manca A; Palermiti A; Mula J; Cusato J; Maiese D; Simiele M; De Nicolò A; D'Avolio A;

A Novel UHPLC-MS/MS Method for the Quantification of Seven Opioids in Different Human Tissues. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2023 Jun 19;16(6):903. doi: 10.3390/ph16060903.
2023
ASL Città di Torino

Manca A; De Nicolò A; De Vivo ED; Ferrara M; Oh S; Khalili S; Higgins N; Deiss RG; Bonora S; Cusato J; Palermiti A; Mula J; Gianella S; D'Avolio A;

2023
ASL Città di Torino

Bonora S; Cinnirella G; D'Avolio A; Marchiaro C; Catellani E; Romano F; Quaranta M; Ranzani FA; Di Vincenzo A; Longo BM; Stroffolini G; De Nicolò A; Gaviraghi A; Venuti F; Calcagno A;

Analytical validation of a novel UHPLC-MS/MS method for 19 antibiotics quantification in plasma: Implementation in a LC-MS/MS Kit. in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie / Biomed Pharmacother. 2023 Jul;163:114790. doi: 10.1016/j.biopha.2023.114790. Epub 2023 Apr 29.
2023
ASL Città di Torino
AOU San Luigi di Orbassano

De Nicolò A; De Rosa FG; Di Perri G; Simiele M; Cusato J; Maiese D; Palermiti A; Manca A; Chiara F; Mula J; D'Avolio A;

A combined role for low vitamin D and low albumin circulating levels as strong predictors of worse outcome in COVID-19 patients. in Irish journal of medical science / Ir J Med Sci. 2023 Feb;192(1):423-430. doi: 10.1007/s11845-022-02952-9. Epub 2022 Feb 19.
2023
ASL Città di Torino

di Masi A; Cusato J; Koncan R; Di Bella S; Zerbato V; Segat L; Sanson G; De Nicolò A; Palermo A; Caironi P; D'Agaro P; Luzzati R; D'Avolio A;

Pharmacokinetics and pharmacogenetics of high-dosage tedizolid for disseminated nocardiosis in a lung transplant patient. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2023 Dec 1;78(12):3003-3004. doi: 10.1093/jac/dkad299.
2023
ASL Città di Torino
AOU Città della Salute di Torino

D'Avolio A; Mangiapia M; Cusato J; Mornese Pinna S; Scabini S; De Nicolò A; Corcione S; Vita D; De Rosa FG;

Antifungal Drug Plasma Exposures: A Possible Contribution of Vitamin D-Related Gene Variants. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2022 May 20;15(5):630. doi: 10.3390/ph15050630.
2022
ASL Città di Torino
AOU San Luigi di Orbassano

D'Avolio A; Calcagno A; Rosa FG; Chiara F; Di Perri G; Allegra S; De Francia S; De Nicolò A; Antonucci M; Manca A; Mula J; Palermiti A; Cusato J;

Factors Influencing the Intracellular Concentrations of the Sofosbuvir Metabolite GS-331007 (in PBMCs) at 30 Days of Therapy. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2022 Mar 15;15(3):355. doi: 10.3390/ph15030355.
2022
ASL Città di Torino

Cusato J; Boglione L; De Nicolò A; Caviglia GP; Mornese Pinna S; Ciancio A; Troshina G; Smedile A; Antonucci M; Avataneo V; Palermiti A; Mula J; Manca A; Cariti G; Cantù M; Saracco GM; Di Perri G; D'Avolio A;

A description of Cannabinoid levels in Cannabis oil by high-performance liquid chromatography-mass spectrometry in a reference laboratory of North-Italy. in Phytomedicine : international journal of phytotherapy and phytopharmacology / Phytomedicine. 2022 Jul 20;102:154218. doi: 10.1016/j.phymed.2022.154218. Epub 2022 May 28.
2022
ASL Città di Torino

Manca A; Palermiti A; Mula J; De Vivo ED; Zeaiter S; Simiele M; De Nicolò A; Cantù M; Cusato J; D'Avolio A;

2022
ASL Città di Torino

Avataneo V; Palermiti A; De Nicolò A; Cusato J; Giussani G; Calcagno A; D'Avolio A;

Pharmacokinetic of Cefiderocol in Critically Ill Patients Receiving Renal Replacement Therapy: A Case Series. in Antibiotics (Basel, Switzerland) / Antibiotics (Basel). 2022 Dec 16;11(12):1830. doi: 10.3390/antibiotics11121830.
2022
ASL Asti
ASL Città di Torino
AOU Città della Salute di Torino

De Rosa FG; Di Perri G; D'Avolio A; Mula J; Lupia T; Vita D; De Benedetto I; Scabini S; De Nicolò A; Montrucchio G; Mornese Pinna S; Corcione S;

A new UHPLC-MS/MS method for cannabinoids determination in human plasma: A clinical tool for therapeutic drug monitoring. in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie / Biomed Pharmacother. 2022 Dec;156:113899. doi: 10.1016/j.biopha.2022.113899. Epub 2022 Oct 21.
2022
ASL Città di Torino
AOU San Luigi di Orbassano

De Filippis G; Vischia F; De Cori D; Cusato J; D'Avolio A; De Nicolò A; Imperiale D; Maiese D; Mula J; Zeaiter S; Palermiti A; Manca A; Chiara F;

Indirect hyperbilirubinemia and jaundice during chronic hepatitis C in an HIV-infected patient treated with glecaprevir/pibrentasvir (GLE/PIB) and antiretroviral therapy (ART). The first reported case in Italy. in Journal of preventive medicine and hygiene / J Prev Med Hyg. 2022 Oct 27;63(3):E420-E423. doi: 10.15167/2421-4248/jpmh2022.63.3.2137. eCollection
2022
ASL Città di Torino

Mastroianni A; Vangeli V; Greco S; Chidichimo L; Urso F; Mauro MV; Bonora S; DE Nicolò A; D'Avolio A;

2021
ASL Città di Torino
AOU Città della Salute di Torino

De Rosa FG; Di Perri G; Stella M; D'Avolio A; Corgiat Loia R; Romeo MR; Pensa A; Lupia T; Segala FV; Corcione S; De Nicolò A;

Seasonal Variation of Antiretroviral Drug Exposure during the Year: The Experience of 10 Years of Therapeutic Drug Monitoring. in Biomedicines / Biomedicines. 2021 Sep 12;9(9):1202. doi: 10.3390/biomedicines9091202.
2021
ASL Città di Torino

Cusato J; Mula J; Palermiti A; Manca A; Antonucci M; Avataneo V; De Vivo ED; Ianniello A; Calcagno A; Di Perri G; De Nicolò A; D'Avolio A;

Pharmacokinetics of bictegravir, emtricitabine and tenofovir alafenamide in a gastrectomized patient with HIV. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2021 Nov 12;76(12):3320-3322. doi: 10.1093/jac/dkab319.
2021
ASL Città di Torino

Tempestilli M; D'Avolio A; De Nicolò A; Agrati C; Antinori A; Cicalini S;

Analysis of Cannabinoids Concentration in Cannabis Oil Galenic Preparations: Harmonization between Three Laboratories in Northern Italy. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2021 May 14;14(5):462. doi: 10.3390/ph14050462.
2021
ASL Città di Torino

Palermiti A; Cafaro A; Barco S; Bucchioni P; Franceschini P; Cusato J; De Nicolò A; Manca A; De Vivo ED; Russo E; Cecchi F; Pigliasco F; Lillo F; Tripodi G; D'Avolio A; Cangemi G;

2021
ASL Città di Torino

De Nicolò A; Manca A; Ianniello A; Palermiti A; Calcagno A; Ferrara M; Antonucci M; Cusato J; Avataneo V; De Vivo E; Bonora S; De Rosa FG; Di Perri G; D'Avolio A;

Rifampicin and Isoniazid Maximal Concentrations are Below Efficacy-associated Thresholds in the Majority of Patients: Time to Increase the Doses? in International journal of antimicrobial agents / Int J Antimicrob Agents. 2021 Mar;57(3):106297. doi: 10.1016/j.ijantimicag.2021.106297. Epub 2021 Fe
2021
ASL Città di Torino

Bonora S; Di Perri G; D'Avolio A; Piccioni P; De Nicolò A; Barco A; Rossi G; Costa C; Pirriatore V; Antonucci M; Motta I; Borgogno E; Trentalange A; Calcagno A;

2021
ASL Città di Torino
AOU Città della Salute di Torino

Romagnoli R; Canaparo R; Tandoi F; Catalano S; Serpe L; Dell'Olio D; D'Avolio A; Antonucci M; Pizzol A; De Nicolò A; Pinon M; Calvo PL;

Low Tenofovir Plasma Exposure in HIV Oral Pre-exposure Prophylaxis Recipients with Gastrointestinal Disorders. in Antimicrobial agents and chemotherapy / Antimicrob Agents Chemother. 2021 Jan 1;65(1):e01902-20. doi: 10.1128/AAC.01902-20. Epub 2020 Oct 26
2021
ASL Città di Torino

Calcagno A; Dal Conte I; Cattaneo D; Testi R; Mistrangelo M; Gervasoni C; de Nicolò A; Bonora S; D'Avolio A; Di Perri G;

Real-life study on the pharmacokinetic of remdesivir in ICU patients admitted for severe COVID-19 pneumonia. in British journal of clinical pharmacology / Br J Clin Pharmacol. 2021 Dec;87(12):4861-4867. doi: 10.1111/bcp.14895. Epub 2021 Jul 4.
2021
ASL Città di Torino

Corcione S; De Nicolò A; Montrucchio G; Scabini S; Avataneo V; Bonetto C; Mornese Pinna S; Cusato J; Canta F; Urbino R; Di Perri G; Brazzi L; De Rosa FG; D'Avolio A;

A Non-Invasive Method for Detection of Antihypertensive Drugs in Biological Fluids: The Salivary Therapeutic Drug Monitoring. in Frontiers in pharmacology / Front Pharmacol. 2022 Jan 5;12:755184. doi: 10.3389/fphar.2021.755184. eCollection 2021.
2021
ASL Città di Torino
AOU Città della Salute di Torino

Veglio F; D'Avolio A; De Rosa FG; Cusato J; Pappaccogli M; Palermiti A; De Nicolò A; Rabbia F; Fanelli E; Avataneo V;

25-Hydroxyvitamin D Concentrations Are Lower in Patients with Positive PCR for SARS-CoV-2. in Nutrients / Nutrients. 2020 May 9;12(5):1359. doi: 10.3390/nu12051359.
2020
ASL Città di Torino

D'Avolio A; Avataneo V; Manca A; Cusato J; De Nicolò A; Lucchini R; Keller F; Cantù M;

Pharmacokinetics of meropenem in burn patients with infections caused by Gram-negative bacteria: Are we getting close to the right treatment? in Journal of global antimicrobial resistance / J Glob Antimicrob Resist. 2020 Mar;20:22-27. doi: 10.1016/j.jgar.2019.06.011. Epub 2019 Jun 14.
2020
ASL Città di Torino
AOU Città della Salute di Torino

Romeo M; Di Perri G; Stella M; De Rosa FG; Loia RC; Pensa A; Segala FV; De Nicolò A; Fatiguso G; Corcione S; D'Avolio A;

Data on the stability of darunavir/cobicistat suspension after tablet manipulation. in Data in brief / Data Brief. 2020 Apr 12;30:105552. doi: 10.1016/j.dib.2020.105552. eCollection 2020 Jun.
2020
ASL Città di Torino

Minghetti P; Tomasello C; Maximova N; Cilurzo F; D'Avolio A; Musazzi UM; De Nicolò A; Zanon D; Manca A;

Effect of Gender and Age on Voriconazole Trough Concentrations in Italian Adult Patients. in European journal of drug metabolism and pharmacokinetics / Eur J Drug Metab Pharmacokinet. 2020 Jun;45(3):405-412. doi: 10.1007/s13318-019-00603-6.
2020
ASL Città di Torino
AOU San Luigi di Orbassano

Antonucci M; D'Avolio A; Manca A; Avataneo V; Cusato J; Allegra S; De Francia S; De Nicolò A;

2020
ASL Città di Torino

Avataneo V; de Nicolò A; Cusato J; Antonucci M; Manca A; Palermiti A; Waitt C; Walimbwa S; Lamorde M; di Perri G; D'Avolio A;

Plasmatic and intracellular concentration of entecavir during treatment of a symptomatic flare in HBV-HDV decompensated cirrhosis. in Journal of infection and public health / J Infect Public Health. 2020 Feb;13(2):315-316. doi: 10.1016/j.jiph.2019.12.005. Epub 2020 Jan 15.
2020
ASL Città di Torino

De Benedetto I; Boglione L; Salvador E; Lupia T; De Nicolò A; Di Perri G; Lipani F; Lucchini AM;

Validation of a UHPLC-MS/MS Method to Quantify Twelve Antiretroviral Drugs within Peripheral Blood Mononuclear Cells from People Living with HIV. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2020 Dec 25;14(1):12. doi: 10.3390/ph14010012.
2020
ASL Città di Torino

De Nicolò A; Ianniello A; Ferrara M; Avataneo V; Cusato J; Antonucci M; De Vivo E; Waitt C; Calcagno A; Trentalange A; Muccioli G; Bonora S; Di Perri G; D'Avolio A;

Data on compounding lopinavir and ritonavir suspension for non-cooperative COVID-19 patients. in Data in brief / Data Brief. 2020 Dec;33:106445. doi: 10.1016/j.dib.2020.106445. Epub 2020 Oct 23.
2020
ASL Città di Torino

Minghetti P; Tomasello C; Clementi E; Maximova N; Cilurzo F; D'Avolio A; De Nicolò A; Manca A; Zanon D; Musazzi UM;

The effect of vitamin D pathway genes and deferasirox pharmacogenetics on liver iron in thalassaemia major patients. in The pharmacogenomics journal / Pharmacogenomics J. 2019 Oct;19(5):417-427. doi: 10.1038/s41397-019-0071-7. Epub 2019 Jan 17.
2019
ASL Città di Torino
AOU San Luigi di Orbassano

Piga A; De Nicolò A; Avataneo V; Massano D; Pirro E; Longo F; De Francia S; Cusato J; Allegra S; D'Avolio A;

LC-MS application for therapeutic drug monitoring in alternative matrices. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2019 Mar 20;166:40-51. doi: 10.1016/j.jpba.2018.12.040. Epub 2018 Dec 29.
2019
ASL Città di Torino

Avataneo V; D'Avolio A; Cusato J; Cantù M; De Nicolò A;

Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate are not transported by Concentrative Nucleoside Transporter 2. in Diagnostic microbiology and infectious disease / Diagn Microbiol Infect Dis. 2019 Jun;94(2):202-204. doi: 10.1016/j.diagmicrobio.2018.07.001. Epub 20
2019
ASL Città di Torino

Cusato J; Calcagno A; De Nicolò A; Mogyorosi K; D'Avolio A; Di Perri G; Bonora S;

Daptomycin Plasma and CSF Levels in Patients with Healthcare-Associated Meningitis. in Neurocritical care / Neurocrit Care. 2019 Aug;31(1):116-124. doi: 10.1007/s12028-018-0657-y.
2019
ASL Città di Torino

Piva S; Di Paolo A; Galeotti L; Ceccherini F; Cordoni F; Signorini L; Togni T; De Nicolò A; Rasulo FA; Fagoni N; Latronico N; D'Avolio A;

2019
ASL Città di Torino

Boglione L; De Nicolò A; Di Perri G; D'Avolio A;

Role of CYP1A1, ABCG2, CYP24A1 and VDR gene polymorphisms on the evaluation of cardiac iron overload in thalassaemia patients. in Pharmacogenetics and genomics / Pharmacogenet Genomics. 2018 Sep;28(9):199-206. doi: 10.1097/FPC.0000000000000348.
2018
ASL Città di Torino
AOU San Luigi di Orbassano

Piga A; De Nicolò A; Avataneo V; Pirro E; Massano D; De Francia S; Longo F; Cusato J; Allegra S; D'Avolio A;

A simple UHPLC-PDA method with a fast dilute-and-shot sample preparation for the quantification of canrenone and its prodrug spironolactone in human urine samples. in Journal of pharmacological and toxicological methods / J Pharmacol Toxicol Methods. 2018 Nov-Dec;94(Pt 2):29-35. doi: 10.1016/j.vascn.2018.08.003. Epub 201
2018
ASL Città di Torino
AOU Città della Salute di Torino

Di Perri G; Veglio F; Mulatero P; Favata F; Allegra S; Fatiguso G; Perlo E; Cusato J; Tosello F; Sciandra M; Rabbia F; Avataneo V; De Nicolò A; D'Avolio A; Avataneo V; De Nicolò A; Rabbia F; Sciandra M; Tosello F; Cusato J; Perlo E; Fatiguso G; Allegra S; Favata F; Mulatero P; Veglio F; Di Perri G; D'Avolio A;

Therapeutic drug monitoring-guided definition of adherence profiles in resistant hypertension and identification of predictors of poor adherence. in British journal of clinical pharmacology / Br J Clin Pharmacol. 2018 Nov;84(11):2535-2543. doi: 10.1111/bcp.13706. Epub 2018 Aug 15.
2018
ASL Città di Torino
AOU Città della Salute di Torino

D'Avolio A; Cusato J; Pappaccogli M; Berra E; Burrello J; Perlo E; Rabbia F; De Nicolò A; Avataneo V; Di Perri G; Veglio F; Avataneo V; De Nicolò A; Rabbia F; Perlo E; Burrello J; Berra E; Pappaccogli M; Cusato J; D'Avolio A; Di Perri G; Veglio F;

Role of CYP24A1, VDR and GC gene polymorphisms on deferasirox pharmacokinetics and clinical outcomes. in The pharmacogenomics journal / Pharmacogenomics J. 2018 May 22;18(3):506-515. doi: 10.1038/tpj.2017.43. Epub 2017 Nov 21.
2018
ASL Città di Torino
AOU San Luigi di Orbassano

Piga A; De Nicolò A; Massano D; Pirro E; Longo F; Arduino A; De Francia S; Cusato J; Allegra S; D'Avolio A; Allegra S; Cusato J; De Francia S; Arduino A; Longo F; Pirro E; Massano D; De Nicolò A; Piga A; D'Avolio A;

Vitamin D pathway gene polymorphisms and hepatocellular carcinoma in chronic hepatitis C-affected patients treated with new drugs. in Cancer chemotherapy and pharmacology / Cancer Chemother Pharmacol. 2018 Mar;81(3):615-620. doi: 10.1007/s00280-018-3520-0. Epub 2018 Jan 22
2018
ASL Città di Torino

Cusato J; Boglione L; De Nicolò A; Favata F; Ariaudo A; Mornese Pinna S; Guido F; Avataneo V; Cantù M; Carcieri C; Cariti G; Di Perri G; D'Avolio A;

Pharmacogenetics of the anti-HCV drug sofosbuvir: a preliminary study. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2018 Jun 1;73(6):1659-1664. doi: 10.1093/jac/dky053.
2018
ASL Città di Torino

Cusato J; De Nicolò A; Boglione L; Favata F; Ariaudo A; Mornese Pinna S; Carcieri C; Guido F; Avataneo V; Cariti G; Di Perri G; D'Avolio A;

Vitamin D pathway gene polymorphisms affecting daclatasvir plasma concentration at 2 weeks and 1 month of therapy. in Pharmacogenomics / Pharmacogenomics. 2018 Jun 1;19(8):701-707. doi: 10.2217/pgs-2018-0009. Epub 2018 May 23.
2018
ASL Città di Torino

Cusato J; De Nicolò A; Boglione L; Favata F; Ariaudo A; Pinna SM; Carcieri C; Guido F; Cariti G; Di Perri G; D'Avolio A;

Vitamin D pathway genetic variants are able to influence sofosbuvir and its main metabolite pharmacokinetics in HCV mono-infected patients. in Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases / Infect Genet Evol. 2018 Jun;60:42-47. doi: 10.1016/j.meegid.2018.02.016. Epub 2018 Feb 13.
2018
ASL Città di Torino

Cusato J; De Nicolò A; Boglione L; Favata F; Ariaudo A; Mornese Pinna S; Carcieri C; Guido F; Avataneo V; Cariti G; Di Perri G; D'Avolio A;

Therapeutic drug monitoring of voriconazole for treatment and prophylaxis of invasive fungal infection in children. in British journal of clinical pharmacology / Br J Clin Pharmacol. 2018 Jan;84(1):197-203. doi: 10.1111/bcp.13401. Epub 2017 Sep 24.
2018
ASL Città di Torino
AOU San Luigi di Orbassano

D'Avolio A; Di Perri G; De Nicolò A; Cusato J; Pirro E; Carcieri C; De Francia S; Favata F; Fatiguso G; Allegra S; Allegra S; Fatiguso G; De Francia S; Favata F; Pirro E; Carcieri C; De Nicolò A; Cusato J; Di Perri G; D'Avolio A;

Cannabinoids concentration variability in cannabis olive oil galenic preparations. in The Journal of pharmacy and pharmacology / J Pharm Pharmacol. 2018 Jan;70(1):143-149. doi: 10.1111/jphp.12845. Epub 2017 Oct 23.
2018
ASL Città di Torino
AOU San Luigi di Orbassano

Di Perri G; Canzoneri L; Cusato J; Avataneo V; De Nicolò A; Simiele M; Tomasello C; D'Avolio A; Carcieri C; Carcieri C; Tomasello C; Simiele M; De Nicolò A; Avataneo V; Canzoneri L; Cusato J; Di Perri G; D'Avolio A;

Effect of ABCC2 and ABCG2 Gene Polymorphisms and CSF-to-Serum Albumin Ratio on Ceftriaxone Plasma and Cerebrospinal Fluid Concentrations. in Journal of clinical pharmacology / J Clin Pharmacol. 2018 Dec;58(12):1550-1556. doi: 10.1002/jcph.1266. Epub 2018 Jun 6.
2018
ASL Città di Torino

Allegra S; Cardellino CS; Fatiguso G; Cusato J; De Nicolò A; Avataneo V; Bonora S; D'Avolio A; Di Perri G; Calcagno A;

Role of ribavirin in the treatment of hepatitis C virus-associated mixed cryoglobulinemia with interferon-free regimens. in Archives of virology / Arch Virol. 2018 Apr;163(4):961-967. doi: 10.1007/s00705-017-3684-7. Epub 2018 Jan 9.
2018
ASL Città di Torino

Boglione L; Cusato J; Pinna SM; De Nicolò A; Cariti G; Di Perri G; D'Avolio A;

2018
ASL Città di Torino

De Nicolò A; Boglione L; Cusato J; Fatiguso G; Favata F; Allegra S; Cariti G; Di Perri G; D'Avolio A;

The role of ITPA and ribavirin transporter genes polymorphisms in prediction of ribavirin-induced anaemia in chronic hepatitis C Egyptian patients. in Clinical and experimental pharmacology & physiology / Clin Exp Pharmacol Physiol. 2017 Sep;44(9):965-968. doi: 10.1111/1440-1681.12786.
2017
ASL Città di Torino

El Desoky ES; Abdelhafez AT; Cusato J; Kamel SI; Hussein AM; De Nicolo A; Di Perri G; D'Avolio A;

A simple high performance liquid chromatography-mass spectrometry method for Therapeutic Drug Monitoring of isavuconazole and four other antifungal drugs in human plasma samples. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2017 Oct 25;145:718-724. doi: 10.1016/j.jpba.2017.07.040. Epub 2017 Aug 5.
2017
ASL Città di Torino

Fatiguso G; Favata F; Zedda I; De Nicolò A; Cusato J; Avataneo V; Di Perri G; D'Avolio A;

Influence of ABCB11 and HNF4? genes on daclatasvir plasma concentration: preliminary pharmacogenetic data from the Kineti-C study. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2017 Oct 1;72(10):2846-2849. doi: 10.1093/jac/dkx237.
2017
ASL Città di Torino

Cusato J; De Nicolò A; Boglione L; Favata F; Ariaudo A; Mornese Pinna S; Guido F; Avataneo V; Carcieri C; Cariti G; Di Perri G; D'Avolio A;

Efficacy of sofosbuvir and ledipasvir in an HCV+ gastro-resected patient. in Journal of clinical pharmacy and therapeutics / J Clin Pharm Ther. 2017 Oct;42(5):621-623. doi: 10.1111/jcpt.12546. Epub 2017 May 4.
2017
ASL Città di Torino

Taibi C; Tempestilli M; D'Avolio A; Garbuglia AR; De Nicolò A; Montalbano M; D'Offizi G;

Treatment with direct-acting antiviral agents of hepatitis C virus infection in injecting drug users: A prospective study. in Journal of viral hepatitis / J Viral Hepat. 2017 Oct;24(10):850-857. doi: 10.1111/jvh.12711. Epub 2017 Apr 25.
2017
ASL Città di Torino

Boglione L; Mornese Pinna S; De Nicolò A; Cusato J; Cariti G; Di Perri G; D'Avolio A;

Evaluation of Posaconazole Pharmacokinetics in Adult Patients with Invasive Fungal Infection. in Biomedicines / Biomedicines. 2017 Nov 20;5(4):66. doi: 10.3390/biomedicines5040066.
2017
ASL Città di Torino
AOU San Luigi di Orbassano

D'Avolio A; Di Perri G; Cusato J; Pirro E; Carcieri C; De Nicolò A; Favata F; De Francia S; Fatiguso G; Allegra S;

Pharmacokinetic evaluation of oral itraconazole for antifungal prophylaxis in children. in Clinical and experimental pharmacology & physiology / Clin Exp Pharmacol Physiol. 2017 Nov;44(11):1083-1088. doi: 10.1111/1440-1681.12822. Epub 2017 Sep 5
2017
ASL Città di Torino
AOU San Luigi di Orbassano

D'Avolio A; Di Perri G; De Nicolò A; Cusato J; Carcieri C; De Francia S; Favata F; Pirro E; Fatiguso G; Allegra S;

2017
ASL Città di Torino

Simiele M; Ariaudo A; De Nicolò A; Favata F; Ferrante M; Carcieri C; Bonora S; Di Perri G; De Avolio A;

Pharmacogenetic analysis of hepatitis C virus related mixed cryoglobulinemia. in Pharmacogenomics / Pharmacogenomics. 2017 May;18(7):607-611. doi: 10.2217/pgs-2016-0040. Epub 2017 Apr 28.
2017
ASL Città di Torino

Cusato J; Boglione L; De Nicolò A; Cardellino CS; Carcieri C; Cariti G; Di Perri G; D'Avolio A;

Association of vitamin D pathway SNPs and clinical response to interferon in a cohort of HBeAg-negative patients. in Pharmacogenomics / Pharmacogenomics. 2017 May;18(7):651-661. doi: 10.2217/pgs-2016-0041. Epub 2017 Apr 28.
2017
ASL Città di Torino

Cusato J; Boglione L; De Nicolò A; Imbornone R; Cardellino CS; Ghisetti V; Carcieri C; Cariti G; Di Perri G; D'Avolio A;

2017
ASL Città di Torino
AOU Città della Salute di Torino

Tandoi F; Romagnoli R; Nonnato A; Calvo PL; Pisciotta C; De Nicolò A; Pinon M; Pensi D; Di Perri G; D'Avolio A;

Role of simeprevir plasma concentrations in HCV treated patients with dermatological manifestations. in Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver / Dig Liver Dis. 2017 Jun;49(6):705-708. doi: 10.1016/j.dld.2017.01.144. Epub 2017 Jan 17.
2017
ASL Città di Torino

Boglione L; De Nicolò A; Mornese Pinna S; Cusato J; Favata F; Ariaudo A; Carcieri C; Cariti G; Di Perri G; D'Avolio A;

Matrix effect management in liquid chromatography mass spectrometry: the internal standard normalized matrix effect. in Bioanalysis / Bioanalysis. 2017 Jul;9(14):1093-1105. doi: 10.4155/bio-2017-0059. Epub 2017 Jul 24.
2017
ASL Città di Torino

De Nicolò A; Cantù M; D'Avolio A;

Treatment with PEG-IFN and ribavirin in patients with chronic hepatitis C, low grade of hepatic fibrosis, genotype 1 and 4 and favorable IFNL3 genotype: A pharmacogenetic prospective study. in Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases / Infect Genet Evol. 2017 Jul;51:167-172. doi: 10.1016/j.meegid.2017.03.014. Epub 2017 Mar 16.
2017
ASL Città di Torino

Boglione L; Cardellino CS; Cusato J; De Nicolò A; Cariti G; Di Perri G; D'Avolio A;

Treatment with daclatasvir and sofosbuvir for 24 weeks without ribavirin in cirrhotic patients who failed first-generation protease inhibitors. in Infection / Infection. 2017 Feb;45(1):103-106. doi: 10.1007/s15010-016-0962-3. Epub 2016 Nov 16.
2017
ASL Città di Torino

Boglione L; Pinna SM; Cardellino CS; De Nicolò A; Cusato J; Carcieri C; Cariti G; Di Perri G; D'Avolio A;

UHPLC-MS/MS method with sample dilution to test therapeutic adherence through quantification of ten antihypertensive drugs in urine samples. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2017 Aug 5;142:279-285. doi: 10.1016/j.jpba.2017.05.018. Epub 2017 May 13.
2017
ASL Città di Torino
AOU Città della Salute di Torino

D'Avolio A; Di Perri G; Veglio F; Mulatero P; Perlo E; Cusato J; Tosello F; Sciandra M; Rabbia F; De Nicolò A; Avataneo V; De Nicolò A; Avataneo V; Rabbia F; Sciandra M; Tosello F; Cusato J; Perlo E; Mulatero P; Veglio F; Di Perri G; D'Avolio A;

UHPLC-MS/MS method with protein precipitation extraction for the simultaneous quantification of ten antihypertensive drugs in human plasma from resistant hypertensive patients. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2016 Sep 10;129:535-541. doi: 10.1016/j.jpba.2016.07.049. Epub 2016 Aug 1.
2016
ASL Città di Torino
AOU Città della Salute di Torino

Di Perri G; Veglio F; Mulatero P; Perlo E; Tomasello C; Cusato J; Bonifacio G; Rabbia F; Avataneo V; De Nicolò A; D'Avolio A;

Entecavir plasma concentrations are inversely related to HBV-DNA decrease in a cohort of treatment-naïve patients with chronic hepatitis B. in International journal of antimicrobial agents / Int J Antimicrob Agents. 2016 Sep;48(3):324-7. doi: 10.1016/j.ijantimicag.2016.05.016. Epub 2016 Jul
2016
ASL Città di Torino

Boglione L; De Nicolò A; Cusato J; Bonifacio G; Cariti G; Di Perri G; D'Avolio A;

Antihypertensive Bridge Therapy by Continuous Drug Infusion With an Elastomeric Pump in Device-Resistant Hypertension. in Hypertension (Dallas, Tex. : 1979) / Hypertension. 2016 Mar;67(3):e3-4. doi: 10.1161/HYPERTENSIONAHA.115.06978. Epub 2016 Jan 18.
2016
ASL Città di Torino
AOU Città della Salute di Torino

Veglio F; Taddei S; Mulatero P; Bruno RM; Berra E; De Nicolò A; Fulcheri C; Bernini G; D'Avolio A; Rabbia F;

A UHPLC-MS/MS method for the quantification of direct antiviral agents simeprevir, daclatasvir, ledipasvir, sofosbuvir/GS-331007, dasabuvir, ombitasvir and paritaprevir, together with ritonavir, in human plasma. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2016 Jun 5;125:369-75. doi: 10.1016/j.jpba.2016.04.031. Epub 2016 Apr 20.
2016
ASL Città di Torino

Ariaudo A; Favata F; De Nicolò A; Simiele M; Paglietti L; Boglione L; Cardellino CS; Carcieri C; Di Perri G; D'Avolio A;

Pharmacogenetics of ribavirin-induced anemia in HCV patients. in Pharmacogenomics / Pharmacogenomics. 2016 Jun;17(8):925-41. doi: 10.2217/pgs.16.22. Epub 2016 Jun 1.
2016
ASL Città di Torino

D'Avolio A; Cusato J; De Nicolò A; Allegra S; Di Perri G;

Vitamin D pathway gene polymorphisms as predictors of hepatitis C virus-related mixed cryoglobulinemia. in Pharmacogenetics and genomics / Pharmacogenet Genomics. 2016 Jun;26(6):307-10. doi: 10.1097/FPC.0000000000000223.
2016
ASL Città di Torino

Cusato J; Boglione L; De Nicolò A; Cardellino CS; Carcieri C; Cariti G; Di Perri G; D'Avolio A;

Physical and Chemical Stability of Urapidil in 0.9% Sodium Chloride in Elastomeric Infusion Pump. in International journal of pharmaceutical compounding / Int J Pharm Compd. 2016 Jul-Aug;20(4):343-346.
2016
ASL Città di Torino
AOU Città della Salute di Torino

De Perri G; De Nicolò A; Fulcheri C; Baietto L; Rabbia F; Veglio F; Leggieri A; D'Avolio A; Tomasello C;

UHPLC-MS/MS method with automated on-line solid phase extraction for the quantification of entecavir in peripheral blood mononuclear cells of HBV+ patients. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2016 Jan 25;118:64-69. doi: 10.1016/j.jpba.2015.10.017. Epub 2015 Oct 22.
2016
ASL Città di Torino

Di Perri G; Tomasello C; Pensi D; Cusato J; Boglione L; Bonifacio G; De Nicolò A; D'Avolio A; De Nicolò A; Bonifacio G; Boglione L; Cusato J; Pensi D; Tomasello C; Di Perri G; D'Avolio A;

A Possible Role of Therapeutic Drug Monitoring in Virological Breakthrough during Simeprevir and PEG-IFN Treatment in HCV-4. in Intervirology / Intervirology. 2016;59(5-6):283-284. doi: 10.1159/000477809. Epub 2017 Jun 22.
2016
ASL Città di Torino

Boglione L; Ruggiero T; De Nicolò A; D'Avolio A; Di Perri G;

A LC-MS method to quantify tenofovir urinary concentrations in treated patients. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2015 Oct 10;114:8-11. doi: 10.1016/j.jpba.2015.05.001. Epub 2015 May 8.
2015
ASL Città di Torino

Simiele M; Carcieri C; De Nicolò A; Ariaudo A; Sciandra M; Calcagno A; Bonora S; Di Perri G; D'Avolio A;

UPLC-MS/MS method for the simultaneous quantification of anti-HBV nucleos(t)ides analogs: Entecavir, lamivudine, telbivudine and tenofovir in plasma of HBV infected patients. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2015 Oct 10;114:127-32. doi: 10.1016/j.jpba.2015.05.016. Epub 2015 May 22.
2015
ASL Città di Torino

De Nicolò A; Simiele M; Pensi D; Boglione L; Allegra S; Di Perri G; D'Avolio A;

UPLC-MS/MS method with automated on-line SPE for the isomer-specific quantification of the first-generation anti-HCV protease inhibitors in peripheral blood mononuclear cells. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2015 Nov 10;115:443-9. doi: 10.1016/j.jpba.2015.08.004. Epub 2015 Aug 4.
2015
ASL Città di Torino

De Nicolò A; Abdi AM; Boglione L; Baiett L; Allegra S; Di Perri G; D'Avolio A;

An UPLC-MS/MS method coupled with automated on-line SPE for quantification of tacrolimus in peripheral blood mononuclear cells. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2015 Mar 25;107:512-7. doi: 10.1016/j.jpba.2015.01.054. Epub 2015 Feb 7.
2015
ASL Città di Torino
AOU Città della Salute di Torino

Di Perri G; Brunati A; Nonnato A; Calvo PL; Pinon M; De Nicolò A; Pensi D; D'Avolio A;

Role of CYP27B1+2838 promoter polymorphism in the treatment of chronic hepatitis B HBeAg negative with PEG-interferon. in Journal of viral hepatitis / J Viral Hepat. 2015 Mar;22(3):318-27. doi: 10.1111/jvh.12288. Epub 2014 Jul 24.
2015
ASL Città di Torino

Boglione L; Cusato J; De Nicolò A; Cariti G; Di Perri G; D'Avolio A;

Intracellular accumulation of boceprevir according to plasma concentrations and pharmacogenetics. in International journal of antimicrobial agents / Int J Antimicrob Agents. 2015 Jun;45(6):657-61. doi: 10.1016/j.ijantimicag.2015.01.019. Epub 2015 Ma
2015
ASL Città di Torino

Cusato J; Allegra S; De Nicolò A; Boglione L; Fatiguso G; Abdi AM; Cariti G; Di Perri G; D'Avolio A;

ABCB11 and ABCB1 gene polymorphisms impact on telaprevir pharmacokinetic at one month of therapy. in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie / Biomed Pharmacother. 2015 Feb;69:63-9. doi: 10.1016/j.biopha.2014.11.007. Epub 2014 Nov 15.
2015
ASL Città di Torino

Cusato J; Allegra S; De Nicolò A; Boglione L; Fatiguso G; Cariti G; Ciancio A; Smedile A; Strona S; Troshina G; Rizzetto M; Di Perri G; D'Avolio A;

Role of pharmacogenetic in ribavirin outcome prediction and pharmacokinetics in an Italian cohort of HCV-1 and 4 patients. in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie / Biomed Pharmacother. 2015 Feb;69:47-55. doi: 10.1016/j.biopha.2014.10.030. Epub 2014 Nov 6.
2015
ASL Città di Torino

Allegra S; Cusato J; De Nicolò A; Boglione L; Gatto A; Cariti G; Di Perri G; D'Avolio A;

Relationship between the early boceprevir-S isomer plasma concentrations and the onset of breakthrough during HCV genotype 1 triple therapy. in Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases / Clin Microbiol Infect. 2015 Feb;21(2):205.e1-3. doi: 10.1016/j.cmi.2014.07.009. Epub 2014 Oct 29.
2015
ASL Città di Torino

Boglione L; De Nicolò A; Cardellino CS; Ruggiero T; Ghisetti V; Cariti G; Di Perri G; D'Avolio A;

VDR gene polymorphisms impact on anemia at 2 weeks of anti-HCV therapy: a possible mechanism for early RBV-induced anemia. in Pharmacogenetics and genomics / Pharmacogenet Genomics. 2015 Apr;25(4):164-72. doi: 10.1097/FPC.0000000000000123.
2015
ASL Città di Torino

Cusato J; Allegra S; Boglione L; De Nicolò A; Cariti G; Di Perri G; D'Avolio A;

SLC29A1 polymorphism and prediction of anaemia severity in patients with chronic hepatitis C receiving triple therapy with telaprevir. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2015 Apr;70(4):1155-60. doi: 10.1093/jac/dku519. Epub 2015 Jan 11.
2015
ASL Città di Torino

Milazzo L; Peri AM; Mazzali C; Magni C; Calvi E; De Nicolò A; Clementi E; Cheli S; D'Avolio A; Antinori S; Falvella FS;

Intracellular and Plasma Trough Concentration and Pharmacogenetics of Telaprevir. in Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques / J Pharm Pharm Sci. 2015;18(2):171-6. doi: 10.18433/j3dk6t.
2015
ASL Città di Torino

Cusato J; Allegra S; De Nicolò A; Boglione L; Fatiguso G; Mohamed Abdi A; Cariti G; Di Perri G; D'Avolio A;

Vitamin D pathway gene variants and HCV-2/3 therapy outcomes. in Antiviral therapy / Antivir Ther. 2015;20(3):335-41. doi: 10.3851/IMP2853. Epub 2014 Oct 3.
2015
ASL Città di Torino

Cusato J; Allegra S; Boglione L; De Nicolò A; Baietto L; Cariti G; Di Perri G; D'Avolio A;

Telaprevir-S isomer enhances ribavirin exposure and the ribavirin-related haemolytic anaemia in a concentration-dependent manner. in Antiviral research / Antiviral Res. 2014 Sep;109:7-14. doi: 10.1016/j.antiviral.2014.06.005. Epub 2014 Jun 20.
2014
ASL Città di Torino

De Nicolò A; Boglione L; Ciancio A; Cusato J; Strona S; Cardellino CS; Abdi AM; Cariti G; Troshina G; Caviglia GP; Smedile A; Rizzetto M; Di Perri G; D'Avolio A;

UPLC-MS/MS method for quantification of the azathioprine metabolites 6-mercaptoguanosine and 6-methylmercaptopurine riboside in peripheral blood mononuclear cells. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2014 Sep;98:271-8. doi: 10.1016/j.jpba.2014.05.040. Epub 2014 Jun 7.
2014
ASL Città di Torino

De Nicolò A; Agnesod D; Simiele M; Riganò D; Adriani A; Canaparo R; Astegiano M; Rizzetto M; Di Perri G; D'Avolio A;

Different HBsAg decline after 3 years of therapy with entecavir in patients affected by chronic hepatitis B HBeAg-negative and genotype A, D and E. in Journal of medical virology / J Med Virol. 2014 Nov;86(11):1845-50. doi: 10.1002/jmv.24038. Epub 2014 Aug 8.
2014
ASL Città di Torino

Boglione L; Cardellino CS; De Nicolò A; Cariti G; Di Perri G; D'Avolio A;

Development and validation of a useful UPLC-MS/MS method for quantification of total and phosphorylated-ribavirin in peripheral blood mononuclear cells of HCV+ patients. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2014 Mar;90:119-26. doi: 10.1016/j.jpba.2013.11.027. Epub 2013 Dec 1.
2014
ASL Città di Torino

Agnesod D; De Nicolò A; Simiele M; Mohamed Abdi A; Boglione L; Di Perri G; D'Avolio A;

Identification of naïve HVC-4 patients who may be treated with pegylated-interferon and ribavirin according to IL28B polymorphisms. in Antiviral research / Antiviral Res. 2014 Jun;106:105-10. doi: 10.1016/j.antiviral.2014.03.016. Epub 2014 Apr 12.
2014
ASL Città di Torino

Boglione L; Cusato J; De Nicolò A; Cariti G; Allegra S; Ghisetti V; Di Perri G; D'Avolio A;

Triple or dual therapy for HCV-1 naive patients? Optimizing selection tools. in Journal of hepatology / J Hepatol. 2014 Jul;61(1):178-9. doi: 10.1016/j.jhep.2014.02.035. Epub 2014 Mar 21.
2014
ASL Città di Torino

Boglione L; De Nicolò A; Di Perri G; D'Avolio A;

Intracellular antiviral activity of low-dose ritonavir in boosted protease inhibitor regimens. in Antimicrobial agents and chemotherapy / Antimicrob Agents Chemother. 2014 Jul;58(7):4042-7. doi: 10.1128/AAC.00104-14. Epub 2014 May 5.
2014
ASL Città di Torino

De Nicolò A; Simiele M; Calcagno A; Abdi AM; Bonora S; Di Perri G; D'Avolio A;

Significant early higher ribavirin plasma concentrations in patients receiving a triple therapy with pegylated interferon, ribavirin and telaprevir. in Journal of viral hepatitis / J Viral Hepat. 2014 Apr;21(4):260-3. doi: 10.1111/jvh.12170. Epub 2013 Sep 2.
2014
ASL Città di Torino

Boglione L; De Nicolò A; Cusato J; Cariti G; Di Perri G; D'Avolio A;

Association of ITPA polymorphisms rs6051702/rs1127354 instead of rs7270101/rs1127354 as predictor of ribavirin-associated anemia in chronic hepatitis C treated patients. in Antiviral research / Antiviral Res. 2013 Oct;100(1):114-9. doi: 10.1016/j.antiviral.2013.07.021. Epub 2013 Aug 8.
2013
ASL Città di Torino

D'Avolio A; De Nicolò A; Cusato J; Ciancio A; Boglione L; Strona S; Cariti G; Troshina G; Caviglia GP; Smedile A; Rizzetto M; Di Perri G;

A UPLC-MS/MS method for the simultaneous plasma quantification of all isomeric forms of the new anti-HCV protease inhibitors boceprevir and telaprevir. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2013 May 5;78-79:217-23. doi: 10.1016/j.jpba.2013.02.025. Epub 2013 Feb 27.
2013
ASL Città di Torino

D'Avolio A; De Nicolò A; Agnesod D; Simiele M; Mohamed Abdi A; Dilly Penchala S; Boglione L; Cariti G; Di Perri G;

Sequential therapy with entecavir and PEG-INF in patients affected by chronic hepatitis B and high levels of HBV-DNA with non-D genotypes. in Journal of viral hepatitis / J Viral Hepat. 2013 Apr;20(4):e11-9. doi: 10.1111/jvh.12018. Epub 2013 Feb 18.
2013
ASL Città di Torino

Boglione L; D'Avolio A; Cariti G; Milia MG; Simiele M; De Nicolò A; Ghisetti V; Di Perri G;

Development and validation of a useful HPLC-UV method for quantification of total and phosphorylated-ribavirin in blood and erythrocytes of HCV+ patients. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2012 Jul;66:376-80. doi: 10.1016/j.jpba.2012.03.030. Epub 2012 Mar 28.
2012
ASL Città di Torino

D'Avolio A; De Nicolò A; Simiele M; Turini S; Agnesod D; Boglione L; Cusato J; Baietto L; Cariti G; Calcagno A; Sciandra M; Di Perri G; Bonora S;

©2024 Tutti i diritti riservati. Biblioteca Virtuale per la Salute - Piemonte